The Danish pharmaceutical company Lundbeck was fined 93.8 million euros by the European Commission, or about 15 billion Icelandic krónur. This was due to unlawful collusion between Lundbeck and manufacturers of generic medicines, delaying the launch of generic versions of the antidepressant Citalopram.
The full story can be found on mbl.is
However, a mbl.is report incorrectly states that this is the highest fine the European Commission has ever imposed on a company. Both the Intel and Philips cases involved significantly higher fines.
"*" indicates required fields
